We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Hedge Fund's AIA Attack Should Have Biotech Cos. Wary

Law360, New York (March 9, 2015, 2:16 PM EDT) -- A hedge fund's attempt to invalidate Acorda Therapeutics Inc. drug patents under the America Invents Act as an investment strategy to lower the company's stock price should have biotechnology companies on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.